Gregory J. Mossinghoff

Gregory J. Mossinghoff

Fundador en Tavros Therapeutics, Inc. .

Health Technology
Consumer Services
Commercial Services

Perfil

Gregory J.
Mossinghoff
was the founder of Integrated Oncology Solutions, Inc. (founded in 2006) and Novolipid, Inc. (founded in 2010) where he held the titles of President & Chief Executive Officer.
He is also the founder of Tavros Therapeutics, Inc. Mr. Mossinghoff's former jobs include President, Chief Business Officer & Director at Inspire Pharmaceuticals, Inc. (1998-2005), Executive Vice President & Chief Business Officer at Zoion Pharma, Inc. (2010-2015), and Secretary & Chief Business Officer at G1 Therapeutics, Inc. (2015-2018).
Mr. Mossinghoff received his undergraduate degree from the University of Virginia and his MBA from George Mason University.

Cargos activos de Gregory J. Mossinghoff

EmpresasCargoInicio
Fundador -
Todos los cargos activos de Gregory J. Mossinghoff

Antiguos cargos conocidos de Gregory J. Mossinghoff.

EmpresasCargoFin
G1 THERAPEUTICS, INC. Corporate Officer/Principal 01/01/2018
Corporate Officer/Principal 01/01/2015
Director Ejecutivo 01/01/2013
Integrated Oncology Solutions, Inc. Director Ejecutivo 01/01/2010
Presidente 01/01/2005
Ver el detalle de la experiencia de Gregory J. Mossinghoff.

Formación de Gregory J. Mossinghoff.

University of Virginia Undergraduate Degree
George Mason University Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Gregory J. Mossinghoff.

Relaciones

30

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas1
G1 THERAPEUTICS, INC.

Health Technology

Empresas privadas5

Health Technology

Integrated Oncology Solutions, Inc.

Health Technology

Health Technology

Commercial Services

Ver las conexiones de la empresa
  1. Bolsa de valores
  2. Insiders
  3. Gregory J. Mossinghoff
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA